Former director (through FY2025) · BIOCRYST PHARMACEUTICALS INC (BCRX)

George B. Abercrombie director compensation at Biocryst: $30.6K

Fiscal year 2025 director compensation for George B. Abercrombie at BIOCRYST PHARMACEUTICALS INC. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 23, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get George B. Abercrombie’s full pay file as a PDF — free

More than this page: up to 10 years of George’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track George B. Abercrombie and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

BIOCRYST PHARMACEUTICALS Director Compensation Table · all 3 fiscal years held
In US dollars, as BIOCRYST PHARMACEUTICALS reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$30,598$0$0—$30,598
FY2024$67,500$42,966$227,500—$337,966
FY2023$68,333$136,974$227,430—$432,737

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: BIOCRYST PHARMACEUTICALS INC DEF 14A filed April 23, 2026, accession 0001628280-26-026822, and prior-year filings. Open the filing on EDGAR.

How this page was built: the BIOCRYST PHARMACEUTICALS INC filed document, accession 0001628280-26-026822. Every figure is read from that document and cited to the page and table it appears in. Filed April 23, 2026.

Get the BIOCRYST PHARMACEUTICALS Board Governance Report

$30,598 George B. Abercrombie, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 23, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

BIOCRYST PHARMACEUTICALS pays directors a $45,000 cash retainer and $325,000 in 60% stock options and 40% RSUs.

The rest of the BIOCRYST PHARMACEUTICALS board

FY2025 · as the company reported each
DirectorRoleFY2025 total
A. Machelle SandersIndependent Director$385,253
Alan G. LevinIndependent Director$397,496
Amy E. McKee, M.DIndependent Director$389,996
Charles K. GayerDirector—
Jill C. Milne, Ph.DIndependent Director—
Jon P. StonehouseDirector—
Stephen J. AselageIndependent Director$33,475
Steven K. Galson, M.D., MPHIndependent Director$385,584
Steven R. FrankIndependent Director$396,489
Theresa M. HeggieIndependent Director$401,700
Vincent J. MilanoIndependent Director$403,695

The full BIOCRYST PHARMACEUTICALS compensation record

free company brief

This page is one director within BIOCRYST PHARMACEUTICALS's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the BIOCRYST PHARMACEUTICALS proxy · each links to its own free brief

Order BCRX

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report